Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: relation to development of knee or hip joint destruction
Open Access
- 1 February 1997
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 56 (2) , 91-96
- https://doi.org/10.1136/ard.56.2.91
Abstract
OBJECTIVE To examine the hypothesis that aggrecan, cartilage oligomeric matrix protein (COMP), and bone sialoprotein (BSP) concentrations in synovial fluid could provide information on variations of progression of joint destruction in rheumatoid arthritis. METHODS Aggrecan, COMP, and BSP were quantified by enzyme linked immunosorbent assays in longitudinally collected knee joint synovial fluid samples of patients rapidly developing destruction in knees or hips, the “destructive” group, n = 18, and in patients slowly developing destruction, the “non-destructive” group, n = 25. RESULTS The aggrecan concentrations decreased from initially high levels (P << 0.001), and the BSP concentrations increased (P << 0.001) over time in the destructive group, whereas levels of both markers were low and did not change in the non-destructive group. The COMP levels did not change in any of the groups. The aggrecan concentrations were initially highest in the group developing destructions (P << 0.001), whereas no difference between the groups was found regarding levels of COMP or BSP in the first sample. CONCLUSIONS A destructive group was characterised by higher initial aggrecan concentrations and rising BSP concentrations in synovial fluid with time. Quantification of cartilage and bone derived macromolecules contributes to the assessment of extent of tissue destruction and may help in the early identification of patients at risk of rapidly progressing destruction.Keywords
This publication has 24 references indexed in Scilit:
- Increased release of bone sialoprotein into synovial fluid reflects tissue destruction in rheumatoid arthritisArthritis & Rheumatism, 1995
- Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcomeArthritis & Rheumatism, 1994
- Acute phase proteins in the monitoring of inflammatory disordersBailliere's Clinical Rheumatology, 1994
- PREDICTORS OF WORSENING CLINICAL VARIABLES AND OUTCOMES IN RHEUMATOID ARTHRITISRheumatic Disease Clinics of North America, 1994
- Distribution and synthesis of bone sialoprotein in metaphyseal bone of young rats show a distinctly different pattern from that of osteopontin.1994
- Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants.1994
- BODY FLUID MARKERS OF CARTILAGE CHANGES IN OSTEOARTHRITISRheumatic Disease Clinics of North America, 1993
- DO NONIMMUNOLOGICALLY MEDIATED PATHWAYS PLAY A ROLE IN THE PATHOGENESIS OF RHEUMATOID ARTHRITIS?Rheumatic Disease Clinics of North America, 1993
- CARTILAGE OLIGOMERIC MATRIX PROTEIN: A NOVEL MARKER OF CARTILAGE TURNOVER DETECTABLE IN SYNOVIAL FLUID AND BLOODRheumatology, 1992
- Markers of bone and collagen breakdown in early inflammatory arthritisBailliere's Clinical Rheumatology, 1992